BOSTON and SAN DIEGO, Nov. 11, 2025 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the ...
Sophia Genetics and Element Biosciences have teamed up to advance genomic sequencing and workflows for precision medicine. Announced during the Association for Molecular Pathology (AMP) meeting, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results